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The purpose of the research was to treat immunodeficient mice, implanted with
colon-25 tumors, with continuous and interrupted electrochemical therapy (ECT). ECT
involves the placement of two electrodes, an anode near the center of the tumor and a cathode
into the tumor periphery.  A constant voltage is applied across the electrodes for a given
period of time. The data showed that the interrupted and continuous ECT resulted in a
decrease in mean tumor growth as compared to that of the sham controls. The histology of
both ECT groups showed an increase presence of large vacuoles, randomly distributed tumor
cells as well as the presence of “crevicing” in the medullary tissue. The differential leukocyte
counts showed a distinct neutrophilia and lymphopenia in all groups at day 20 post tumor
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For a number of years, medical practice in Asia and Europe has seen a growth in the
use of less invasive therapeutic approaches or the incorporation of  alternative medicine for
the treatment and prevention of diseases and chronic disorders.  These practices are less
accepted by western practitioners (Laken and Cosovic, 1995).  Many of these alternative
procedures emanate from ancient practices, often techniques that were employed by
indigenous peoples (Micozzi, 1995).  For example, it is now widely recognized in modern
medical science that there are a multitude of plants that were known among ancient peoples
to have medicinal properties, and there are untold numbers of additional plant species whose
extracts may have beneficial medicinal value (Duke, 1995).  Likewise, there are undoubtedly
a number of manipulative/mechanical procedures that have been in use over the centuries or
have gone unexplored that deserve scrutiny using accepted scientific investigative
procedures.  An example of a more invasive mechanical procedure is acupuncture, which has
been applied in Asian cultures for treatment of pulmonary diseases, tumors, tuberculosis, as
well as a number of other diseases and disorders, but has only recently become more
acceptable to western practitioners (Jobst, 1995).  More recently, research employing the
scientific method that incorporates testable hypotheses into its design has been applied to
studies of the effectiveness of acupuncture in the treatment of a variety of disorders (Jobst,
1995).  With the inception of the National Institutes of Health Office of Alternative Medicine
in 1992, the realization that alternative medical procedures deserve scientific validation has
extended to not only the field of medical research but also to the training of medical
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practitioners (Laken and Cosovic, 1995).  It is just such an approach that the research
described herein takes to determine the efficacy of the application of electrical current to
tumors and the potential therapeutic benefits of such a procedure.
Cancer has claimed the lives of millions of people all over the world. This year about
552,200 Americans are expected to die of cancer, more than 1,500 people a day (American
Cancer Society, 2000).  Cancer is the second leading cause of death in the US, exceeded only
by heart disease (American Cancer Society, 2000).  In 2000, about 1, 220, 100 new cancer
cases are expected to be diagnosed and approximately, since 1990, 13 million new cases have
been diagnosed (American Cancer Society, 2000).  Ongoing research for new and better
techniques in treating this deadly disease has led several investigators to report that locally
applied direct current (DC), now called electrochemical treatment (ECT), destroys a variety
of human and animal tumors in vitro and in vivo (Taylor et al., 1994).  ECT involves the
placement of two electrodes, an anode near the center of the tumor and a cathode into the
tumor periphery.  A constant voltage is applied across the electrodes for a given period of
time.
 In 1983, Nordentstrom was the first in recent years to utilize ECT for treating human
tumors.  Electrochemical therapy has been used in China since 1987 resulting in impressive
clinical results (Xin, 1994).  Since 1987, 4,081 cases with malignant tumors have been
treated with ECT (Xin, 1994).  Xin, (1994), reported the most impressive clinical data where
2516 cases from 66 hospitals were treated with ECT.  Of the 2,516 cases, 2,124 patients were
followed up for 1 to 5 years. The survival rates were 84.3% for year 1, 79.1% for year 2,
63.5% for 3 years, 57.8% for 4 years, and 46.6% for 5 years (Xin, 1994).  However, Xin
,(1994), modified the methods introduced by,  Nordenstrom, (1983), by inserting platinum
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anodes near the center of a tumor, and the cathodes were applied in the periphery (Chou et
al., 1995).
Various effects of ECT on tissues have been reported. The direct current, when
applied to the cancer tissue, severely disturbs the living microenvironment of the cell (Chou
et al., 1995).  Due to electrophoresis, electrolysis, and electro-osmosis in the tumor tissues,
the cells near the electrodes do not survive (Chou et al., 1995).  The pH levels at the anode
decrease to 2.0 and increase at the cathode to 13.0 causing the release of chlorine and
hydrogen ions (Chou et al., 1995).  It is believed that these strong acidic and basic conditions
at the electrodes cause cancer cell death by denaturing cell proteins, enzymes and membranes
(Chou et al., 1995).  The worldwide experience with the effects of the application of ECT to
various cancers goes back some 15 years with more than 5,000 patients been treated,
predominantly in China (Xin 1997).  The types of tumors that have been treated include:
esophageal, lung, liver, breast, skin, thyroid, parotid, melanoma, oral cavity and prostrate
cancers (Xin, 1997).  Almost all of the work done on humans has involved patients that
received other standard treatment prior to and/or following ECT.  Relatively little work has
been done on laboratory animals or humans under controlled laboratory conditions, where
potential changes in tumors could be compared to those in control animals receiving no
treatment.
The purpose of the research was to treat immunodeficient mice implanted with colon-
25 tumors with ECT under such controlled conditions.  The specific aims were (1) to measure
the effects of ECT on the growth rate of tumor, (2) changes in histology of the tumors, and
(3) to compare the effects of ECT administered continuously and at 10-sec intervals on the
growth rate of implanted tumors.  Based on the results of this research, we hoped to
demonstrate that ECT administered under controlled laboratory conditions will show some of
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the same beneficial results on tumor growth as seen with clinical data, as well as, to establish




 Forty male and 40 female Balb-c mice, ranging in weight from (17-31g) were
selectively bred at the University of North Texas Animal Care Facility and used in this study.
Balb-c mice were chosen for this study because of their reduced immune system in order to
facilitate the growth of the tumor.  Each mouse was implanted with 2 mm x 2 mm medullary
section (brei) of a human Colon-25 tumor from a donor mouse.  The brei consists of the
medullary section of the tumor sliced up in a petri dish and mixed with a Ringer’s solution to
insure cell viability during implantation (Fig. 1).  This particular tumor was maintained in the
laboratory for approximately 4 yr The 2 mm x 2 mm sections were then injected epidermaly
between the sacral crest and the rib cage posteriorly using a 13-gauge hypodermic needle
(Fig. 1).  The mice were maintained at the University of North Texas Animal Care Facility
and were subjected to  LD 12:12 and were fed a steady diet of TeklabTM rodent pellets.
The electrodes used in the study were fabricated from platinum wires, Epoxylie 6001-
M electrode insulator fluid, DevconTM 5 Minute Epoxy glue, capillary tubing and acrylic.
The platinum wires were coated with insulator fluid and allowed to dry.  The insulation fluid,
at the electrode tips, was removed with a scalpel under a dissecting microscope to create 0.5
mm length tips. Holes, measuring 1 cm apart, were drilled into the acrylic plate.  Capillary
tubes were placed into the holes, and the electrode wires were placed inside.  Capillary tubes
and electrode wires were secured to the acrylic plate with the epoxy glue (Fig. 2).
Electrical current was supplied by Heath KitTM Regulated High Voltage Power
Supply. Current and amperes were measured by two Keithley Instruments TM 602
Electrometers.  The electrodes were secured to a micromanipulator to insure constant steady
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                      Figure 1. Petri Dish, 13 Gauge Hypodermic Needle, and Calipers
                                  Figure 2. Fabricated Electrodes
     Figure 3. Heath Kit Regulated High Voltage Power Supply and Micromanipulator
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electrode movement into and out of the tumor (Fig. 3). The electrodes were applied into the
tumor by inserting the anode into the center of the tumor and the cathode, 1 cm away from
the anode, into the periphery.
The animals were divided into control and experimental groups as follows:
I. Control groups
Group A: control animals with tumor only (10 males and 10
females)
Group B: sham control animals with electrodes implanted on
day 10 post tumor implantation for 10 min. but with no
current (10 males and 10 females)
II. Experimental animal groups
Group A: continuous current ECT (electrochemical therapy)
for 10 min. at day 10 post tumor implantation (10 males and
10 females)
Group B: interrupted current ECT for 10 min. at 10-sec
Intervals at day 10 post tumor implantation (10 males and 10
females)
The measurements and observations taken from each animal were: (1) change in
tumor size measured on the outside of the skin to the nearest mm (length x width = cm2)
using digital calipers  (Fig 1), (2) changes in blood differential counts from blood collected
from the caudal vein using capillary tubes on day 5 and day 20 post tumor implantation using
Diff – Quick TMdifferential stains, and (3) changes in tumor histology.  Instantaneous growth
rates reflecting relative increases in tumor size over the period of application of ECT were
calculated after Brody (1945) as
8
k = lnM2 – lnM1 / t2 – t1
 where M2 and M1 are mean tumor sizes at times t2 and t1, respectively.
Sham control and experimental animals were anesthetized with ketamine diluted in
distilled water (1 ml/10 ml of water) given intrapertoneally.  ECT experiments were
performed approximately on day 10 post tumor implantation, when the tumor reached 1 cm
in length.
X-rays were taken of the mice at day 9 post tumor implantation, just prior to ECT, as
well as on day 20 post tumor implantation prior to euthanasia, tumor removal, and blood
collection.  Photographs of tumors were taken with a 35 mm camera, in situ and following
removal in order to record and measure overt features such as size, shape, color, weight, and
vascularization.
Tumors were measured on a daily basis following day 5 post tumor implantation.  On
day 20 post tumor implantation, the tumors were removed, weighed and placed in a 2%
formalin solution.  Each tumor was embedded in paraffin and sectioned into 16-20 µm
sections using an 820 SpencerTM microtome (Buffalo, New York).  The sections were then
stained using Harris Hamatoxylin 3 and eosin.  Photomicrographs were taken, at 40 X
magnification, using a ZeissTM microscope fitted with a 35 mm Olympus camera.
Statistical analysis of the data was performed using a 2-tailed Students’ t-test. The





The results from the experimental groups appear to support the findings of previous
investigators.  As with the previous investigations, the experimental tumor sizes for the
continuous and interrupted ECT groups showed a significant decrease when compared to the
sham control group.  The data obtained in the study are presented in the form of figures
depicting the rate of growth of each tumor as reflected by changes in daily tumor size.
Photographs and x-rays were also presented to show a typical encapsulated tumor in situ and
a typical excised tumor. Histological changes observed with microscopy demonstrated
changes in both cortical and medullary regions of control and ECT treated tumors
A typical tumor grown in situ shows overall size of the tumor, approximately half the
size of the animal (Fig. 4).  The tumor was solid, well defined and relatively symmetrical.
During early tumor growth stages, growth of tumors progressed posteriorly toward the tail,
but as the tumor continued to increase in size it progressed anteriorly toward the head,
sometimes expanding through the abdominal wall and entering the abdominal cavity.
Excised tumors from both control and experimental groups at day 20 post tumor implantation
showed solid, well-defined forms (Fig 5).
There were also no significant differences in tumor growth between male and female
animals in any of the groups and, therefore data from males and females were combined.
Data comparing the size of tumors in control and sham control groups show no statistically
significant differences in tumor sizes between the two control groups (Fig. 6).   Instantaneous
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Figure 4. X-rays of Colon-25 tumors in situ from Balb-c mice
                    Control                             Sham                   Continuous              Interrupted
                                                                          
               Figure 5. Excised tumors from control and experimental groups at day 2011
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growth rates (k) for sham control and control groups were 0.186 and 0.193, respectively,
between days 5 and 10 and 0.085 and 0.096, respectively, between days 11 and 20.  The
mean size at day 15 post tumor implantation for the control groups was 2.26 cm2, and that for
the sham control groups was 2.32 cm2.  At day 20 post tumor implantation, the mean size for
control groups was 3.21 cm2, while that for the sham control was 3.46 cm2.  The data
presented in Table 1 further confirmed the findings with the percent change between the
control and sham control groups equaling 7.33%, however this difference was not significant.
The standard error of the mean for the control group was .62 and was .86 for the sham control
group
Interrupted ECT resulted in a decrease in mean tumor growth as compared to that of
the sham controls (Fig. 7).  Mean tumor sizes for the Interrupted ECT at day 12 post tumor
implantation was 1.33 cm2, at day 15 it was 1.74 cm2, at day 17 it was 2.04 cm2 and at day 20
it was 2.35 cm2 as compared to 1.66 cm2, 2.32 cm2, 2.70 cm2 and 3.46 cm2 for the sham
control at the same time periods, respectively (Table 2).  A comparison of the instantaneous
growth rates calculated for the interrupted ECT experimental group and sham control group
between days 5 and 10, prior to treatment,  indicates comparable rates of growth (k) of 0.223
and 0.186, respectively.  Post-treatment rates for the same groups were 0.074 and 0.085,
respectively (Fig. 7), a 13% difference in the growth rate of treated tumors compared to that
of sham controls.
Mean tumor size of the continuous ECT is decreased, as well, when compared to that
of the sham controls (Fig. 8).  Mean tumor size for the continuous ECT at day12 post tumor
implantation was 0.99 cm2, at day 15 it was 1.12 cm2, at day 17 it was 1.41 cm2 and at day 20
it was 1.82 cm2 as compared to mean sizes of tumors of the sham controls (Table 2).  These
differences were shown to be statistically significant (Table 2), and both the interrupted and
13



















































































































































































































































continuous ECT experimental groups had a statistically significant changes in mean tumor
sizes.   A comparison between instantaneous growth rates (k) for continuous ECT
experimental group and the sham control indicates comparable rates of growth, 0.162 and
0.186, respectively, between days 5 and 10 prior to treatment (Fig. 8).  Post-treatment rates of
growth for continuous ECT experimental group and the sham control were 0.062 and 0.085,
respectively (Fig. 9), a 27% difference in growth rate of treated tumors compared to that of
sham controls.
The data indicate that both experimental procedures, interrupted and continuous,
retarded the overall growth of the tumor producing with a percent change difference in tumor
size of –31.7% for interrupted ECT and –47.1% for continuous ECT.  Both differences in
average tumor sizes and instantaneous rates of growth reflected the therapeutic affect of
interrupted and continuous applications of ECT.
There was no correlation between the initial sizes of the tumors, before the ECT was
applied at day 10 post-tumor implantation, and  the overall growth rate of the tumors.  A
CORREL, correlation coefficient test, was run on the continuous and interrupted ECT
groups.  The results showed no  significance between any of the mice in either group.  In fact
there was an inverse correlation between tumor size and growth rate.  The larger initial tumor
grew at a slower rate.
Histological sections of untreated tumors revealed typical tissue morphology with
both the cortex and medulla evident (Fig. 10).  The cortex was composed of well defined
tissue layers interspersed by larger tumor cells with interstitial channels. Separation between
cortex and medulla was evident, where the medullary portion displayed a homogeneous
dispersion of darkly-stained tumor cells.  Both sham and control tumor cells appear to be
evenly distributed throughout the tissue without deterioration or vacuole formation.
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Histology of a continuous ECT treated tumor shows a distinct change in the
medullary portion (Fig. 10).  This was presented by an increased presence of several large
vacuoles, as well as, randomly distributed tumor cells.  Also shown in the medulla is the
presence of “crevicing”.  Interrupted ECT treated tumors also displayed large vacuoles in the




n GROUPS cm2 SEM [%∆] Mean tumor
weights (g)
20 CONTROL 3.20 0.62 0% 1.45
20 SHAM CONTROL 3.44 0.86 7.33% 1.45
%∆= T - C X 100 T = SHAM CONTOL
C C= CONTROL
Statistical significance determined by a
two tailed T test
Table 1.  Summary comparing mean tumor sizes between









20 SHAM CONTROL 3.44 1.45 0.86 0%
20 CONTINUOUS ECT 1.82 1.36 0.48 -47.09% ***
20 INTERRUPTED ECT 2.35 1.34 0.52 -31.69% ***




Statistical significance determined by a
two tailed T test
*** Statistically significant @ p<.001
Table 2.  Summary of the effects of continuous and interrupted ECT on
mean tumor sizes in Balb-c mice on day 20
20
  
                A. Control Tumor                                        B. Sham Control
   
                C. Continuous ECT                                         D. Interrupted ECT
         Figure 9.  Histology sections of colon-25 tumors in Balb-c mice at day 20
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CONTROL GROUP VS. NORMAL UNTREATED
CONTROL
T5 MEAN SEM T20 MEAN SEM %∆
MONOCYTE 2 1.7 1 1.80 -32% *
LYMPHOCYTE 47 17.1 25 30.29 -47% ***
NEUTROPHIL 50 18.2 73 31.35 45% ***
EOSINOPHIL 1 0.9 1 0.68 -10%
BASOPHIL 0 0.85 0 0.68 -33% ***
SHAM CONTROL GROUP VS CONTROL GROUP
T5 MEAN SEM T20 MEAN SEM %∆
MONOCYTE 2 2.19 1 1.74 -49% **
LYMPHOCYTE 53 14.05 17 31.84 -67% ***
NEUTROPHIL 43 14.30 80 32.99 87% ***
EOSINOPHIL 1 0.95 1 0.78 -13%
BASOPHIL 0 0.81 0 0.78 0%
SHAM CONTROL VS. CONTINUOUS ECT
T5 MEAN SEM T20 MEAN SEM %∆
MONOCYTE 4 2.96 1 1.39 -67% **
LYMPHOCYTE 53 9.32 19 7.60 -65% **
NEUTROPHIL 41 7.63 79 8.85 95% **
EOSINOPHIL 1 0.82 2 0.88 11%
BASOPHIL 0 0.55 0 0.64 -56%
SHAM CONTROL VS. INTERUPTED ECT
T5 MEAN SEM T20 MEAN SEM %∆
MONOCYTE 3 2.75 1 1.30 -53%
LYMPHOCYTE 53 11.12 20 9.16 -62% **
NEUTROPHIL 42 9.81 77 10.08 82% **
EOSINOPHIL 1 0.93 1 0.83 -4%
BASOPHIL 0 0.53 0 0.62 0%
% T20 - T5 X 100
T5 T5 = count at day 5
*p<.02, **p.002, ***p<.001, two-tailed
t-test
T20 = count at day 20
Table 3  Summary of the effects of ECT on  mean WBC differential counts in Balb-c mice
             implanted with Colon-25 tumors.
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The effects of ECT on the differential leukocyte counts are summarized in Table 3.
Data depict the change in 100 cell counts from day 5 and day 20 post tumor implantation.
When compared to the differential leukocyte counts in mice without tumors, a distinct
neutrophilia was found at day 20, as well as, a distinct lympopenia in all control and
experimental groups. Control group mean lymphocyte and neutrophil counts on day 5 were
47 and 50 respectively, while at day 20 the mean counts changed to 25 and 73, respectively.
The sham control mean counts at day 5 for lymphocytes was 53 and for neutrophils was 43,
with values of 17 and 80, respectively, at day 20. These effects were also present with the
experimental groups, where interrupted ECT treated groups had mean lymphocyte and
neutrophil counts of 53 and 41 at day 5, respectively, and 19 and 79 at day 20, respectively.
Continuous ECT treated group counts at day 5 were 53 and 42, respectively, and 20 and 77 at
day 20, respectively. ECT, both interrupted and continuous, caused no statistically significant




It was difficult to compare this in vivo study with most of the ECT studies that
predominate the literature.  Most of the previous research is performed on humans using ECT
in conjunction with chemotherapy, radiation and surgery, with no controls. Very few studies
are conducted on animals under controlled laboratory conditions. The few controlled
laboratory studies that were performed on animals reached similar conclusions.  Bohao et al,
(1994), showed that ECT administered to mice with transplanted SRS solid tumors resulted
in at least partial regression or disappearance and increased the survival time for the animals.
Hai-Young and Gan-Zhong, (1994), studied the effect of ECT on immune functions of
normal and tumor-bearing mice, and showed that ECT enhanced both cellular immune
functions of T and B-lymphocytes and non-specific immune functions of the phagocytic
system .  Samuelsson (1994), combined ECT with radiotherapy in rats showing a substantial
necrosis in tumor tissue.
The study was modeled after a study of Heiberg’s (1991), who studied the effects of
different voltages and dosages of ECT on overall effectiveness in nude mice with
subcutaneous human colon cancer.  Heiberg’s (1991), work showed that a 7.5 v current was
the most effective voltage, causing the greatest tumor reduction.  Based on Heiberg’s (1991),
results,  the current study attempted to expand on them following the previous protocol as
much as possible as well as testing whether an interrupted current would have the same or
greater effect than does a continuous current.  There were no statistically significant
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differences between the two treatments.  The mean tumor size for the continuous ECT group
was 1.82 cm2  whole that for  the interrupted group was 2.35 cm2.
What possible mechanisms are involved with the anti-tumor actions of ECT? Tumors
require an increase in blood vessel vasculature (angiogenesis) in order to grow larger than 1-2
mm3 (Folkman, 1990).  In addition to blood supply, tumors require optimal pH and cannot
survive at a pH lower than 6.0 (Dobrowsky et al. 1991).  According to Nordenstrom (1994),
ECT adversely affects tumors due to several factors.  First, since white blood cells, the
primary tumor-fighters of the body, carry negative electric charges, placing a positive
electrode directly into a tumor will attract more of the white blood cells to the tumor itself
(Nordenstrom, 1994).  Second, although cancer cells multiply faster than do normal cells,
they are more vulnerable, the electric field created by ECT should create changes in the
tumor cell environment, of which one would be a chemical reaction around the electrode.
This reaction would be a build-up of Hydrogen ions (Nordenstrom, 1994).  Third, around the
outside of the tumor, the acidic reaction would kill some of the red blood cells or at least
damage their hemoglobin, preventing delivery of oxygen to the tumor (Nordenstrom, 1994).
Forth, the positive electric field should move water out of the tumor, thus shrinking it and
causing the surrounding tissue to swell.  This will increase pressure on the blood vessels,
thereby blocking the flow of blood to the tumor (Nordenstrom, 1994).  Finally, the chemical
reaction at the electrodes would produce a pocket of gas, which could create a high-pressure
cavity that might actually break the tumor mechanically from the inside out (Nordenstrom,
1994).
Young-Xi et al. (1997)hypothesized other therapeutic mechanisms for the impact of
ECT  on growth of tumors.  They proposed that changes were induced to the peripheral
environment of the tumor tissue, hence altering the potential of the cell membrane through
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ionization and making positive and negative ions move  to the electrodes.  They also
suggested that sodium and potassium ions move toward the cathode, carrying away a large
quantity of water ,resulting in desiccated and contracted cells.   Furthermore, the strong acid
causes proteins to condense and precipitate, resulting in a serious disorder of electrolytes,and
acidity, as well as, denaturation and necrosis of the tumor cells.
According to Douwes et al. (1997), ECT effectiveness is attributed to the sensitivity
of tumor cells to changes in their microenvironment over that of normal cells.  Under the
application of ECT, the ionic composition of tissue fluid around cancer cells and the water
content of tissues are altered considerably by electrophoresis and electroosmosis between the
positive and negative electrodes, leading to the destruction of exposed tumor tissue.
The actual mechanism of the necrosis of the tumor and its overall regression from
ECT treatment still remains elusive. But it is widely accepted that the disruption in the tumor
microenvironment resulting in tumor necrosis and regression is a direct result from the
movement of a current between the electrodes.  The present  study confirmed this by  the
appearance of large vacuoles and “crevicing” seen in the histological sections of the
experimental groups.
This study produced a noticeable increase in neutrophil count (neutrophilia)
concomitant to a drop in the lymphocyte count (lymphopenia) at day 20 post tumor
implantation.  These effects were observed in previously unpublished experiments carried out
in this laboratory (Lott, personal comments).  It has also been observed in other studies using
Balb-c mice with mammary adenocarcinoma (Musiani et al. 1996).  These increases in
neutrophil counts might be attributed to ECT’s role in increasing white blood cell recruitment
and production at the site of the tumor.
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Several areas of concern arose during this study.  These centered around technical
problems including  (1) the use of ketamine as an anesthesia in mice, (2) the use of fabricated
electrodes, (3) quantitation of the implants used, and (4) maintaining a constant current
during the experimental procedure.
There was no published information found that presented the dosages needed to
completely anesthetized a 25-g mouse for 10 min.  The small size of the mice made the threat
of over dosage a problem.  During the trials of finding the proper dilutions and dosages to use
safely, several mice died.  The final dilution that was used (1 ml of ketamine/ 10 ml of water)
still caused problems, because the effects of the drug differed with each mouse.  The same
dose that would completely anesthetize a specific mouse either would not have any effect on
another or result in death of a mouse of the same weight.  Gas anesthesia might have had
better results, because it is well suited for smaller mammals.
In regards to the use of fabricated electrodes, it was hard to be completely sure if the
electrodes were constructed properly to ensure the proper transfer of current to the tumors.
The previous studies in the literature purchased and used prefabricated electrodes in order to
insure their proper function (Heiberg, 1991).  Due to the high cost of prefabricated
electrodes, this study was resigned to using those fabricated by the investigator.
In order to address the problem of maintaining a constant current throughout the ECT
experimentation, previous studies found in the literature used a computer controlled power-
supply that continuously monitored the current, making adjustments when needed (Heiberg,
1991).  The high cost of the computer prevented using a continuously controlled current.  The
power-supply used allowed only for the voltage to be controlled and remain constant.  The
current changed with the change in the tumor tissue resistance during ECT experiments.  As
the current was applied, ionic changes due to the release of hydrogen ions and chlorine ions
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caused the resistance of the tissue to change, ultimately altering the current traveling from
electrode to electrode across the tumor.
To accurately measure the amount of tumor implant given to each mouse, a grid was
fixed under a petri dish so that 2 x 2-mm sections could be measured (Fig. 1). The same 13
gauge hypodermic needle was used each time to inject the tumor into the mice in order to
also insure a constant amount of tumor implant. This is a very important aspect of the
research, because size differences in implants could significantly alter the size and rate of
tumor growth.
In summary, the data in this study show that: (1) ECT treatments, both continuous
and interrupted, reduce the overall growth and size of implanted colon-25 tumors in Blab-c
mice, (2) these ECT treatments produce a profound neutrophilia combined with a significant
lymphopenia at day 20 post tumor implantation, and (3) ECT treatments cause histological
changes to the tumor in the medulla increasing the number of vacuoles and appearance of
“crevicing”.
The therapeutic effects of ECT in treating all different forms of cancer can not be
ignored. There have been to many significant positive results, especially from China in the
past 15 years, where methods of alternative medicine have had positive results.  It is crucial
that more research be done into the feasibility of methods such as ECT being a useful
adjuncts in certain cancer therapy protocols.
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